Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -7.04% vs -20.08% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -1.03% vs 0.24% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 150.00% vs 0.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 6.45% vs -1.47% in Mar 2024
Compare Balance Sheet Results of Vista Pharma.
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
12.31
185.90
-173.59
-93.38%
Share Warrants & Outstandings
Total Reserve
33.10
22.57
10.53
46.65%
Shareholder's Funds
45.42
208.46
-163.04
-78.21%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
2.38
0.00
2.38
0.00%
Secured Loans
2.38
0.00
2.38
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-4.37
0.00
-4.37
0.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.12
0.00
0.12
0.00%
Total Non-Current Liabilities
-1.87
212.75
-214.62
-100.88%
Current Liabilities
Trade Payables
5.59
195.02
-189.43
-97.13%
Other Current Liabilities
1.74
35.72
-33.98
-95.13%
Short Term Borrowings
5.02
0.00
5.02
0.00%
Short Term Provisions
0.01
0.00
0.01
0.00%
Total Current Liabilities
12.37
230.74
-218.37
-94.64%
Total Liabilities
55.92
651.96
-596.04
-91.42%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
27.18
0.01
27.17
271,700.00%
Less: Accumulated Depreciation
8.48
0.00
8.48
0.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
18.70
0.00
18.70
0.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
10.14
0.00
10.14
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.05
0.00
0.05
0.00%
Long Term Loans & Advances
2.12
0.00
2.12
0.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
31.01
0.00
31.01
0.00%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
8.22
1.58
6.64
420.25%
Sundry Debtors
13.54
252.19
-238.65
-94.63%
Cash and Bank
0.73
46.57
-45.84
-98.43%
Other Current Assets
0.41
0.00
0.41
0.00%
Short Term Loans and Advances
2.00
351.61
-349.61
-99.43%
Total Current Assets
24.91
651.96
-627.05
-96.18%
Net Current Assets (Including Current Investments)
12.54
421.21
-408.67
-97.02%
Total Current Assets Excluding Current Investments
24.91
651.96
-627.05
-96.18%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
55.92
651.96
-596.04
-91.42%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
7.40
212.75
-205.35
-96.52%
Book Value per share (adjusted)
7.38
1.02
6.36
623.53%
Annual - Borrowings
Borrowings 7.40 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -7.04% vs -20.08% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 28.84 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.03% vs 0.24% in Mar 2024
Annual - Investments
Investments 0.05 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 150.00% vs 0.00% in Mar 2024
Annual - Current Assets
Current Assets 24.91 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.45% vs -1.47% in Mar 2024






